Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab.
Manini MB, Matsunaga NY, Gianfrancesco L, Oliveira MS, Carvalho MRV, Ribeiro GLMT, Morais EO, Ribeiro MAGO, Morcillo AM, Ribeiro JD, Toro AADC.
Manini MB, et al. Among authors: toro aadc.
J Bras Pneumol. 2021 Oct 15;47(5):e20210157. doi: 10.36416/1806-3756/e20210157. eCollection 2021.
J Bras Pneumol. 2021.
PMID: 34669834
Free PMC article.
English, Portuguese.